Bank Of New York Mellon Corp Tyra Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.68 - $8.81 $263,375 - $408,510	46,369 New	46,369 $352,000
Q3 2022 Nov 14, 2022	BUY	$6.61 - $12.42 $48,510 - $91,150	7,339 Added 23.0%	39,250 $345,000
Q2 2022 Aug 15, 2022	BUY	$5.26 - $11.19 $6,790 - $14,446	1,291 Added 4.22%	31,911 $228,000
Q1 2022 May 11, 2022	BUY	$10.03 - $14.09 $100,751 - $141,534	10,045 Added 48.82%	30,620 $328,000
Q4 2021 Feb 11, 2022	BUY	$12.23 - $31.35 $251,632 - $645,026	20,575 New	20,575 $289,000

43.5M

353K

1.1K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $588M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.